Click for best price
Fibromyalgia Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 2945.2 million
|
Forecast Market size by 2029 |
US$ 3308.4 million
|
| Growth Rate |
CAGR of 1.7% |
Number of Pages |
61 Pages |
The global Fibromyalgia Drugs market was valued at US$ 2945.2 million in 2022 and is projected to reach US$ 3308.4 million by 2029, at a CAGR of 1.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.
This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Drugs. This report contains market size and forecasts of Fibromyalgia Drugs in global, including the following market information:
- Global Fibromyalgia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.
We surveyed the Fibromyalgia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fibromyalgia Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fibromyalgia Drugs Market Segment Percentages, by Type, 2022 (%)
Serotonin Norepinephrine Reuptake Inhibitors
GABA Analogs
Other
Global Fibromyalgia Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fibromyalgia Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Fibromyalgia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fibromyalgia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fibromyalgia Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fibromyalgia Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fibromyalgia Drugs, market overview.
Chapter 2: Global Fibromyalgia Drugs market size in revenue.
Chapter 3: Detailed analysis of Fibromyalgia Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibromyalgia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Fibromyalgia Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2945.2 million
|
| Forecast Market size by 2029 |
US$ 3308.4 million
|
| Growth Rate |
CAGR of 1.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fibromyalgia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibromyalgia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fibromyalgia Drugs Overall Market Size
2.1 Global Fibromyalgia Drugs Market Size: 2022 VS 2029
2.2 Global Fibromyalgia Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fibromyalgia Drugs Players in Global Market
3.2 Top Global Fibromyalgia Drugs Companies Ranked by Revenue
3.3 Global Fibromyalgia Drugs Revenue by Companies
3.4 Top 3 and Top 5 Fibromyalgia Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fibromyalgia Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fibromyalgia Drugs Players in Global Market
3.6.1 List of Global Tier 1 Fibromyalgia Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Fibromyalgia Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fibromyalgia Drugs Market Size Markets, 2022 & 2029
4.1.2 Serotonin Norepinephrine Reuptake Inhibitors
4.1.3 GABA Analogs
4.1.4 Other
4.2 By Type - Global Fibromyalgia Drugs Revenue & Forecasts
4.2.1 By Type - Global Fibromyalgia Drugs Revenue, 2018-2023
4.2.2 By Type - Global Fibromyalgia Drugs Revenue, 2024-2029
4.2.3 By Type - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fibromyalgia Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Fibromyalgia Drugs Revenue & Forecasts
5.2.1 By Application - Global Fibromyalgia Drugs Revenue, 2018-2023
5.2.2 By Application - Global Fibromyalgia Drugs Revenue, 2024-2029
5.2.3 By Application - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Fibromyalgia Drugs Market Size, 2022 & 2029
6.2 By Region - Global Fibromyalgia Drugs Revenue & Forecasts
6.2.1 By Region - Global Fibromyalgia Drugs Revenue, 2018-2023
6.2.2 By Region - Global Fibromyalgia Drugs Revenue, 2024-2029
6.2.3 By Region - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Fibromyalgia Drugs Revenue, 2018-2029
6.3.2 US Fibromyalgia Drugs Market Size, 2018-2029
6.3.3 Canada Fibromyalgia Drugs Market Size, 2018-2029
6.3.4 Mexico Fibromyalgia Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Fibromyalgia Drugs Revenue, 2018-2029
6.4.2 Germany Fibromyalgia Drugs Market Size, 2018-2029
6.4.3 France Fibromyalgia Drugs Market Size, 2018-2029
6.4.4 U.K. Fibromyalgia Drugs Market Size, 2018-2029
6.4.5 Italy Fibromyalgia Drugs Market Size, 2018-2029
6.4.6 Russia Fibromyalgia Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Fibromyalgia Drugs Market Size, 2018-2029
6.4.8 Benelux Fibromyalgia Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Fibromyalgia Drugs Revenue, 2018-2029
6.5.2 China Fibromyalgia Drugs Market Size, 2018-2029
6.5.3 Japan Fibromyalgia Drugs Market Size, 2018-2029
6.5.4 South Korea Fibromyalgia Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Fibromyalgia Drugs Market Size, 2018-2029
6.5.6 India Fibromyalgia Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Fibromyalgia Drugs Revenue, 2018-2029
6.6.2 Brazil Fibromyalgia Drugs Market Size, 2018-2029
6.6.3 Argentina Fibromyalgia Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fibromyalgia Drugs Revenue, 2018-2029
6.7.2 Turkey Fibromyalgia Drugs Market Size, 2018-2029
6.7.3 Israel Fibromyalgia Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Fibromyalgia Drugs Market Size, 2018-2029
6.7.5 UAE Fibromyalgia Drugs Market Size, 2018-2029
7 Fibromyalgia Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Fibromyalgia Drugs Major Product Offerings
7.1.4 Pfizer Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Fibromyalgia Drugs Major Product Offerings
7.2.4 Eli Lilly Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Actavis
7.3.1 Actavis Company Summary
7.3.2 Actavis Business Overview
7.3.3 Actavis Fibromyalgia Drugs Major Product Offerings
7.3.4 Actavis Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.3.5 Actavis Key News & Latest Developments
7.4 Merck Sharp and Dohme
7.4.1 Merck Sharp and Dohme Company Summary
7.4.2 Merck Sharp and Dohme Business Overview
7.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Major Product Offerings
7.4.4 Merck Sharp and Dohme Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck Sharp and Dohme Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Fibromyalgia Drugs Major Product Offerings
7.5.4 Daiichi Sankyo Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Innovative Med Concepts
7.6.1 Innovative Med Concepts Company Summary
7.6.2 Innovative Med Concepts Business Overview
7.6.3 Innovative Med Concepts Fibromyalgia Drugs Major Product Offerings
7.6.4 Innovative Med Concepts Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.6.5 Innovative Med Concepts Key News & Latest Developments
7.7 Meda
7.7.1 Meda Company Summary
7.7.2 Meda Business Overview
7.7.3 Meda Fibromyalgia Drugs Major Product Offerings
7.7.4 Meda Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.7.5 Meda Key News & Latest Developments
7.8 Meiji Seika
7.8.1 Meiji Seika Company Summary
7.8.2 Meiji Seika Business Overview
7.8.3 Meiji Seika Fibromyalgia Drugs Major Product Offerings
7.8.4 Meiji Seika Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.8.5 Meiji Seika Key News & Latest Developments
7.9 Switch Biotech
7.9.1 Switch Biotech Company Summary
7.9.2 Switch Biotech Business Overview
7.9.3 Switch Biotech Fibromyalgia Drugs Major Product Offerings
7.9.4 Switch Biotech Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.9.5 Switch Biotech Key News & Latest Developments
7.10 Theravance
7.10.1 Theravance Company Summary
7.10.2 Theravance Business Overview
7.10.3 Theravance Fibromyalgia Drugs Major Product Offerings
7.10.4 Theravance Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.10.5 Theravance Key News & Latest Developments
7.11 Zynerba Pharmaceuticals
7.11.1 Zynerba Pharmaceuticals Company Summary
7.11.2 Zynerba Pharmaceuticals Business Overview
7.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Major Product Offerings
7.11.4 Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.11.5 Zynerba Pharmaceuticals Key News & Latest Developments
7.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
7.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Summary
7.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
7.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Major Product Offerings
7.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue in Global Market (2018-2023)
7.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Fibromyalgia Drugs Market Opportunities & Trends in Global Market
Table 2. Fibromyalgia Drugs Market Drivers in Global Market
Table 3. Fibromyalgia Drugs Market Restraints in Global Market
Table 4. Key Players of Fibromyalgia Drugs in Global Market
Table 5. Top Fibromyalgia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Fibromyalgia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Fibromyalgia Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Fibromyalgia Drugs Product Type
Table 9. List of Global Tier 1 Fibromyalgia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibromyalgia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Fibromyalgia Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Fibromyalgia Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Fibromyalgia Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Fibromyalgia Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Fibromyalgia Drugs Product Offerings
Table 32. Pfizer Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Fibromyalgia Drugs Product Offerings
Table 36. Eli Lilly Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. Actavis Company Summary
Table 39. Actavis Fibromyalgia Drugs Product Offerings
Table 40. Actavis Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Actavis Key News & Latest Developments
Table 42. Merck Sharp and Dohme Company Summary
Table 43. Merck Sharp and Dohme Fibromyalgia Drugs Product Offerings
Table 44. Merck Sharp and Dohme Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Sharp and Dohme Key News & Latest Developments
Table 46. Daiichi Sankyo Company Summary
Table 47. Daiichi Sankyo Fibromyalgia Drugs Product Offerings
Table 48. Daiichi Sankyo Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Daiichi Sankyo Key News & Latest Developments
Table 50. Innovative Med Concepts Company Summary
Table 51. Innovative Med Concepts Fibromyalgia Drugs Product Offerings
Table 52. Innovative Med Concepts Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Innovative Med Concepts Key News & Latest Developments
Table 54. Meda Company Summary
Table 55. Meda Fibromyalgia Drugs Product Offerings
Table 56. Meda Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Meda Key News & Latest Developments
Table 58. Meiji Seika Company Summary
Table 59. Meiji Seika Fibromyalgia Drugs Product Offerings
Table 60. Meiji Seika Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Meiji Seika Key News & Latest Developments
Table 62. Switch Biotech Company Summary
Table 63. Switch Biotech Fibromyalgia Drugs Product Offerings
Table 64. Switch Biotech Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Switch Biotech Key News & Latest Developments
Table 66. Theravance Company Summary
Table 67. Theravance Fibromyalgia Drugs Product Offerings
Table 68. Theravance Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Theravance Key News & Latest Developments
Table 70. Zynerba Pharmaceuticals Company Summary
Table 71. Zynerba Pharmaceuticals Fibromyalgia Drugs Product Offerings
Table 72. Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Zynerba Pharmaceuticals Key News & Latest Developments
Table 74. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Summary
Table 75. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product Offerings
Table 76. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Tonix Pharmaceuticals Holding Corp. (TNXP) Key News & Latest Developments
List of Figures
Figure 1. Fibromyalgia Drugs Segment by Type in 2022
Figure 2. Fibromyalgia Drugs Segment by Application in 2022
Figure 3. Global Fibromyalgia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fibromyalgia Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fibromyalgia Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fibromyalgia Drugs Revenue in 2022
Figure 8. By Type - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Fibromyalgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 16. US Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 28. China Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Fibromyalgia Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Fibromyalgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Actavis Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Sharp and Dohme Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Daiichi Sankyo Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Innovative Med Concepts Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Meda Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Meiji Seika Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Switch Biotech Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Theravance Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zynerba Pharmaceuticals Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
